Absorption Pharmaceuticals
Absorption Pharmaceuticals, a CA-based firm, manufactures FDA-approved PROMESCENT, a lidocaine-based topical anesthetic, using patented absorption technology.
Founded
2008Absorption Pharmaceuticals, a CA-based firm, manufactures FDA-approved PROMESCENT, a lidocaine-based topical anesthetic, using patented absorption technology.
Absorption Pharmaceuticals, founded in 2008 and based in Newport Beach, CA, is dedicated to enhancing sexual wellness through innovative products. The company's core mission is to improve the quality of intimate experiences for couples. Their flagship product, PROMESCENT, is an FDA-approved lidocaine-based topical anesthetic that uses patented transcutaneous absorption technology to help men manage premature ejaculation. The company also offers a range of other sexual wellness products, including erectile dysfunction treatments, supplements, and arousal gels.
Notable individuals affiliated with Absorption Pharmaceuticals include Dr. Ronald Gilbert, the founder and Chief Medical Officer, who developed PROMESCENT. The company has achieved significant market penetration since the product's formal introduction in 2011, earning widespread acceptance from leading urologists and sexual health experts. With millions of satisfied customers and numerous positive reviews, Absorption Pharmaceuticals has made a substantial impact on the sexual wellness industry by providing effective solutions that enhance intimate relationships.
Companies similar to Absorption Pharmaceuticals include Prometheon Pharma, Absorbits, Promentis Pharmaceuticals and Petros Pharmaceuticals.
Absorption Pharmaceuticals was founded in 2008.
Absorption Pharmaceuticals' headquarters is located in Huntington Beach, CA, US.
Absorption Pharmaceuticals' most recent funding round was for $1.2M (USD) in February 2014.
As of Feb 14, 2014, Absorption Pharmaceuticals has raised a total of $1.2M (USD).
Absorption Pharmaceuticals has 31 employees as of Feb 4, 2024.
